Jackmup International Trading Private Limited

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly available in tablet form. It is used to reduce pain, inflammation, and stiffness caused by various conditions, including arthritis (such as rheumatoid arthritis and osteoarthritis) and other inflammatory disorders.
Here is some detailed information about Meloxicam tablets:
Medication Class: Meloxicam belongs to the class of NSAIDs, which work by reducing the production of certain chemicals in the body that cause pain and inflammation.
Indications: Meloxicam is primarily used to relieve pain and inflammation associated with arthritis, including rheumatoid arthritis and osteoarthritis. It may also be prescribed for other conditions such as ankylosing spondylitis and juvenile rheumatoid arthritis.
Dosage and Administration: The dosage of Meloxicam can vary depending on the specific condition being treated and the individual patient's needs. It is typically taken once daily with or without food. The recommended starting dose for most conditions is 7.5 mg per day, which may be increased to a maximum of 15 mg per day if necessary.
Precautions and Warnings: It is important to use Meloxicam with caution and under the guidance of a healthcare professional. Some precautions and warnings include:
Avoid using Meloxicam if you have a known allergy to NSAIDs or a history of allergic reactions to similar medications.Inform your healthcare provider about any pre-existing medical conditions, including heart disease, kidney disease, liver disease, gastrointestinal disorders, asthma, or bleeding disorders.Use with caution in elderly individuals, as they may be more susceptible to side effects.Inform your doctor about all the medications you are currently taking, including over-the-counter drugs, supplements, and herbal products, as they may interact with Meloxicam.Side Effects: Common side effects of Meloxicam may include stomach upset, nausea, vomiting, diarrhea, dizziness, headache, and skin rash. Serious side effects are rare but can include stomach ulcers, gastrointestinal bleeding, liver or kidney problems, and allergic reactions. Seek medical attention if you experience severe or persistent side effects.
Drug Interactions: Meloxicam may interact with certain medications, such as other NSAIDs, anticoagulants (blood thinners), diuretics, ACE inhibitors, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.
Please note that this information is a general overview of Meloxicam tablets, and it is important to follow the specific instructions provided by your healthcare provider and read the medication guide provided with the product.

Flutivate Cream has been belonging to a group of medicines called steroids. It is mainly used for treatment of skin conditions with inflammation and itching such as eczema, dermatitis, and psoriasis. It provide relief from pain, swelling, redness, and itching in several skin problems.

Imutrex Tablet contains Methotrexate as its active ingredient. It is used to treat several types of cancer, including breast cancer, leukemia, and lymphoma, as well as rheumatoid arthritis and psoriasis.
Methotrexate works by stopping the growth of cancer cells and suppressing the immune system in autoimmune diseases such as rheumatoid arthritis and psoriasis.
Imutrex Tablet is typically required orally one time per week, regardless of food, as coordinated by your PCP. The measurements and term of therapy might rely upon the patient's ailment and reaction to treatment.
Common side effects of Imutrex Tablet include nausea, vomiting, loss of appetite, headache, and dizziness. It can also lower blood cell counts, which can increase the risk of infection, so regular blood tests are necessary during treatment.
Serious side effects of Imutrex Tablet may include liver damage, lung problems, and severe skin reactions. It is important to tell your doctor immediately if you experience any unusual symptoms while taking this medication.
Imutrex Tablet should not be used during pregnancy or breastfeeding, as it can harm the developing fetus or infant. It may also interact with other medications, so it is important to inform your doctor of all medications you are taking before starting treatment with Imutrex Tablet.

Paraplatin Injection, containing the active ingredient Carboplatin, is a chemotherapy medication used in the treatment of various types of cancer, including ovarian cancer, lung cancer, and certain types of brain tumors. Carboplatin belongs to a class of drugs known as platinum-based alkylating agents, which work by interfering with the DNA replication process in rapidly dividing cancer cells, ultimately leading to cell death. Understanding its uses, dosage guidelines, and considerations is essential for healthcare providers and patients undergoing cancer treatment.
Uses:
Ovarian Cancer: Paraplatin Injection is commonly used as a first-line or adjuvant treatment for ovarian cancer, either alone or in combination with other chemotherapy drugs or surgical interventions. It is effective in both newly diagnosed cases and recurrent or metastatic ovarian cancer, helping to shrink tumors and slow disease progression.
Lung Cancer: Carboplatin is also utilized in the treatment of non-small cell lung cancer (NSCLC), particularly in combination with other chemotherapy agents such as paclitaxel or gemcitabine. It may be administered as part of first-line therapy for advanced or metastatic lung cancer to improve tumor response rates and overall survival.
Other Cancers: In addition to ovarian and lung cancer, Paraplatin Injection may be used in the treatment of other malignancies, including testicular cancer, bladder cancer, and certain types of brain tumors. Its broad spectrum of activity against various cancer types makes it a versatile and valuable chemotherapy agent in oncology practice.
Dosage:The dosage of Paraplatin Injection (Carboplatin) is determined based on several factors, including the patient's body surface area, renal function, performance status, and the specific type and stage of cancer being treated. It is administered intravenously under the supervision of a healthcare professional experienced in chemotherapy administration.
For ovarian cancer, the typical dosage of Carboplatin is calculated based on the Calvert formula, which takes into account the target area under the concentration-time curve (AUC) desired for the individual patient. Common regimens may involve Carboplatin administered at an AUC of 5 to 7.5 every three to four weeks, either as a single agent or in combination with other chemotherapy drugs such as paclitaxel.
For lung cancer and other solid tumors, Carboplatin dosing may vary depending on the specific treatment protocol and combination regimen used. It is often administered in combination with other chemotherapy agents at doses determined by the treating oncologist based on clinical guidelines and individual patient factors.
Considerations:
Side Effects: Common side effects associated with Paraplatin Injection (Carboplatin) may include nausea, vomiting, fatigue, myelosuppression (decreased blood cell counts), neuropathy, and kidney dysfunction. Patients should be monitored closely for signs of toxicity during and after treatment, and supportive care measures may be provided to manage side effects as needed.
Renal Function: Carboplatin is primarily eliminated from the body via the kidneys, and dosage adjustments may be necessary in patients with impaired renal function to minimize the risk of drug accumulation and toxicity. Renal function should be assessed regularly, and dosage adjustments should be made accordingly to ensure safe and effective treatment.
Hematologic Toxicity: Carboplatin can cause myelosuppression, including neutropenia, thrombocytopenia, and anemia, which may increase the risk of infection, bleeding, and fatigue. Regular monitoring of blood cell counts is essential, and dose modifications may be required based on the degree of hematologic toxicity observed.

Campto Injection contains the active ingredient Irinotecan, which is an antineoplastic medication used in the treatment of certain types of cancer. It belongs to a class of drugs called topoisomerase inhibitors.
Irinotecan works by interfering with the DNA replication process in cancer cells, inhibiting their growth and causing their death. It is commonly used in the treatment of colorectal cancer, particularly in advanced or metastatic stages.
Campto Injection is typically administered intravenously under the supervision of a healthcare professional. The dosage and treatment schedule will be determined by your oncologist based on various factors, including the type and stage of cancer, overall health, and response to treatment.
Common side effects of Irinotecan include nausea, vomiting, diarrhea, loss of appetite, fatigue, hair loss, and decreased white blood cell count. These side effects are usually temporary and can be managed with supportive care medications.
It is important to inform your healthcare provider about any existing medical conditions, medications, or allergies before starting treatment with Campto Injection. Certain conditions or medications may interact with Irinotecan and affect its safety and effectiveness.
During treatment with Irinotecan, regular monitoring of blood counts and liver function is typically performed to assess the body's response and detect any potential side effects.
Please note that the information provided here is a general overview of Campto Injection and its uses. It is not exhaustive, and specific instructions may vary depending on individual circumstances. For detailed guidance and personalized advice, it is best to consult with your oncologist or healthcare provider.

FOLITRAX 7.5MG TABLET contains Methotrexate, which belongs to the group of medicines called Antimetabolites. FOLITRAX 7.5MG TABLET is used to manage active rheumatoid arthritis in adults, which is a form of severe arthritis occurring due to unknown reasons (idiopathic) and old age and is non-responsive to conventional painkillers (such as Non-Steroidal Anti Inflammatory Drugs Ex. Aceclofenac).
FOLITRAX 7.5MG TABLET is also used to manage its polyarthritic forms (characterized by the involvement of five or more joints), which are severe, active, and idiopathic in nature and affect young people (Juvenile Idiopathic Arthritis, JIA).
FOLITRAX 7.5MG TABLET is also used to manage psoriasis and relapsed (reoccurred) and refractory (unaffected by other conventional managements) Non-Hodgkin’s lymphoma, which is a type of cancer of the lymphatic system.
Psoriasis is a skin condition characterized by itchy scales that is not responsive to conventional managements such as phototherapy and retinoids.
Before taking FOLITRAX 7.5MG TABLET, it is recommended to inform the doctor about your medical and family history, including the list of medicines (prescription, non-prescription medicines, and herbal medicines) that are being taken.
Also, FOLITRAX 7.5MG TABLET is not recommended to be taken by pregnant and nursing women, women planning pregnancy, those who drink huge amounts of alcohol, or patients suffering from liver and kidney impairment.
FOLITRAX 7.5MG TABLET is not recommended in children for the management of psoriasis and rheumatoid arthritis. However, FOLITRAX 7.5MG TABLET can be used with caution in children to manage polyarticular juvenile idiopathic arthritis, which is characterized by the involvement of five or more joints that are of severe, active, juvenile, and idiopathic character. Consult the doctor before taking FOLITRAX 7.5MG TABLET.
In addition, caution must be exercised by patients suffering from lung disorders, blood disorders, and gastric disorders before taking FOLITRAX 7.5MG TABLET.
Care must be taken to avoid taking products containing caffeine, such as black tea, coffee, and cold drinks, while taking FOLITRAX 7.5MG TABLET.
The common side effects seen after taking FOLITRAX 7.5MG TABLET are headache, nausea, vomiting, dizziness, and altered levels of blood cells. Consult a doctor if any of the above side effects worsen after taking FOLITRAX 7.5MG TABLET.
USES OF FOLITRAX 7.5MG TABLETIt is used to manage:
Active rheumatoid arthritisPsoriasisArthritis in patients suffering from psoriasis (psoriatic arthritis)

Rebopag Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia.
Rebopag Tablet is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. The function of platelets is to help reduce bleeding.
Take it in the exact dose and duration as advised by the doctor. You may take it on an empty stomach. This medicine is to be swallowed as a whole. Do not chew, crush or break it. Inform your doctor if you have any known allergies to this medication.
The common side effects include nausea, vomiting, diarrhea, upper respiratory tract infection, and urinary tract infection. Let your doctor know if any of these side effects bother you. They may be able able to suggest ways to reduce or treat the symptoms.
Before you take this medicine, inform your doctor if you have any preexisting medical conditions. Let your doctor also know about all the other medicines you are taking. Dose adjustments may be required in patients with liver diseases, inform your doctor.